CXL Ophthalmics bags $32m for minimally-invasive treatment for keratoconus

CXL Ophthalmics (CXLO), an American clinical-stage company, has raised $32 million in a Series A funding round for developing a minimally-invasive treatment for keratoconus, a ... Read More